Filters: author is Mathot [Clear All Filters]
- 2006
Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery,
Anesthesiology, vol. 105, no. 6, pp. 1135-46. DOI
- 1997
Time course of action of three adenosine A1 receptor agonists with differing lipophilicity in rats: comparison of pharmacokinetic, haemodynamic and EEG effects,
Naunyn Schmiedebergs Arch Pharmacol, vol. 356, no. 6, pp. 827-37.
- 1996
Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo,
J Pharmacol Exp Ther, vol. 279, no. 3, pp. 1439-46.
- 1995
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor,
J Med Chem, vol. 38, no. 20, pp. 4000-6.
Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo,
Br J Pharmacol, vol. 116, no. 3, pp. 1957-64.
Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine,
J Pharmacol Exp Ther, vol. 275, no. 1, pp. 245-53.
Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats,
Br J Pharmacol, vol. 114, no. 4, pp. 761-8.
8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor,
Eur J Pharmacol, vol. 290, no. 3, pp. 189-99.
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline,
Br J Pharmacol, vol. 115, no. 7, pp. 1253-9.
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive rats,
J Pharmacol Exp Ther, vol. 273, no. 1, pp. 405-14.
- 1994
Assessment of the enantiomeric purity of R- and S-N6-phenylisopropyladenosine (PIA): implications for adenosine receptor subclassification,
Naunyn Schmiedebergs Arch Pharmacol, vol. 350, no. 1, pp. 109-12.
Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat,
J Pharmacol Exp Ther, vol. 268, no. 2, pp. 616-24.
Partial agonism of theophylline-7-riboside on adenosine receptors,
Naunyn Schmiedebergs Arch Pharmacol, vol. 350, no. 6, pp. 638-45.
Liquid chromatographic determination of the adenosine receptor agonist CGS 21680 in blood using on-line solid-phase extraction on a phenylboronic acid support and fluorescence detection,
J Chromatogr B Biomed Appl, vol. 658, no. 1, pp. 207-12.
- 1993
Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives,
Eur J Drug Metab Pharmacokinet, vol. 18, no. 1, pp. 41-7.


